Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example

por Bruxvoort, Katia, Sy, Lina S., Ackerson, Bradley K., Slezak, Jeff, Qian, Lei, Towner, William, Reynolds, Kristi, Solano, Zendi, Carlson, Cheryl M., Jacobsen, Steven J.
Publicado 2021

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–...

por Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Xie, Fagen, Ackerson, Bradley K, Valluri, Srinivas R, Jodar, Luis, McLaughlin, John M
Publicado 2022

Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants

por Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Xie, Fagen, Ackerson, Bradley K, Valluri, Srinivas R, Jodar, Luis, McLaughlin, John M.
Publicado 2022

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model

por Patterson, Brandon J, Herring, William L, Van Oorschot, Desiree, Curran, Desmond, Carrico, Justin, Zhang, Yuanhui, Ackerson, Bradley K, Bruxvoort, Katia, Sy, Lina S, Tseng, Hung-Fu
Publicado 2020

Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System

por Malden, Deborah E, Tartof, Sara Y, Ackerson, Bradley K, Hong, Vennis, Skarbinski, Jacek, Yau, Vincent, Qian, Lei, Fischer, Heidi, Shaw, Sally F, Caparosa, Susan, Xie, Fagen
Publicado 2022

Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Ye...

por Tartof, Sara Y., Frankland, Timothy B., Slezak, Jeff M., Puzniak, Laura, Hong, Vennis, Xie, Fagen, Ackerson, Bradley K., Valluri, Srinivas R., Jodar, Luis, McLaughlin, John M.
Publicado 2022

Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system...

por Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Frankland, Timothy B, Xie, Fagen, Ackerson, Bradley K, Valluri, Srinivas R, Jodar, Luis, McLaughlin, John M
Publicado 2023

Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study

por Bruxvoort, Katia J., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Lee, Gina S., Tian, Yun, Florea, Ana, Takhar, Harpreet S., Tubert, Julia E., Talarico, Carla A., Tseng, Hung Fu
Publicado 2021

Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study

por Florea, Ana, Sy, Lina S., Luo, Yi, Qian, Lei, Bruxvoort, Katia J., Ackerson, Bradley K., Lee, Gina S., Ku, Jennifer H., Tubert, Julia E., Tian, Yun, Talarico, Carla A., Tseng, Hung Fu
Publicado 2022

Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19

por Skarbinski, Jacek, Liu, Liyan, Hong, Vennis, Amsden, Laura B, Fireman, Bruce H, Yau, Vincent M, Incerti, Devin, Qian, Lei, Fischer, Heidi, Ackerson, Bradley K, Shaw, Sally F, Tartof, Sara Y
Publicado 2022

Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system

por Lewnard, Joseph A, McLaughlin, John M, Malden, Debbie, Hong, Vennis, Puzniak, Laura, Ackerson, Bradley K, Lewin, Bruno J, Kim, Jeniffer S, Shaw, Sally F, Takhar, Harpreet, Jodar, Luis, Tartof, Sara Y
Publicado 2023

Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study

por Ku, Jennifer H., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Tubert, Julia E., Lee, Gina S., Florea, Ana, Bruxvoort, Katia J., Talarico, Carla A., Qiu, Sijia, Tian, Yun, Tseng, Hung Fu
Publicado 2023

BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5

por Tartof, Sara Y, Slezak, Jeff M, Puzniak, Laura, Hong, Vennis, Frankland, Timothy B, Ackerson, Bradley K, Takhar, Harpreet, Ogun, Oluwaseye A, Simmons, Sarah, Zamparo, Joann M, Jodar, Luis, McLaughlin, John M
Publicado 2022

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults

por Florea, Ana, Sy, Lina S, Qian, Lei, Ackerson, Bradley K, Luo, Yi, Tubert, Julia E, Lee, Gina S, Ku, Jennifer H, Bruxvoort, Katia J, Talarico, Carla A, Qiu, Sijia, Tian, Yun, Tseng, Hung Fu
Publicado 2022

BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5–11 Years of Age: A Test Negative Design

por Tartof, Sara Y, Frankland, Timothy B, Puzniak, Laura, Slezak, Jeff M, Hong, Vennis, Takhar, Harpreet, Ogun, Oluwaseye A, Simmons, Sarah, Xie, Fagen, Zamparo, Joann, Ackerson, Bradley K, Jodar, Luis, McLaughlin, John M
Publicado 2023

Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system

por Malden, Deborah E., Gee, Julianne, Glenn, Sungching, Li, Zhuoxin, Mercado, Cheryl, Ogun, Oluwaseye A., Kim, Sunhea, Lewin, Bruno J., Ackerson, Bradley K., Jazwa, Amelia, Weintraub, Eric S., McNeil, Michael M., Tartof, Sara Y.
Publicado 2023

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study

por Ku, Jennifer H., Sy, Lina S., Qian, Lei, Ackerson, Bradley K., Luo, Yi, Tubert, Julia E., Lee, Gina S., Florea, Ana, Bruxvoort, Katia J., Xie, Fagen, Qiu, Sijia, Chavers, Scott, Talarico, Carla A., Tseng, Hung Fu
Publicado 2023

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

por Bruxvoort, Katia J, Sy, Lina S, Qian, Lei, Ackerson, Bradley K, Luo, Yi, Lee, Gina S, Tian, Yun, Florea, Ana, Aragones, Michael, Tubert, Julia E, Takhar, Harpreet S, Ku, Jennifer H, Paila, Yamuna D, Talarico, Carla A, Tseng, Hung Fu
Publicado 2021

Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

por Tseng, Hung Fu, Ackerson, Bradley K., Luo, Yi, Sy, Lina S., Talarico, Carla A., Tian, Yun, Bruxvoort, Katia J., Tubert, Julia E., Florea, Ana, Ku, Jennifer H., Lee, Gina S., Choi, Soon Kyu, Takhar, Harpreet S., Aragones, Michael, Qian, Lei
Publicado 2022

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

por Tseng, Hung Fu, Ackerson, Bradley K., Luo, Yi, Sy, Lina S., Talarico, Carla A., Tian, Yun, Bruxvoort, Katia J., Tubert, Julia E., Florea, Ana, Ku, Jennifer H., Lee, Gina S., Choi, Soon Kyu, Takhar, Harpreet S., Aragones, Michael, Qian, Lei
Publicado 2022